Unable to load price data. Sorry.

¯\_(ツ)_/¯

Insys Therapeutics (NASDAQOTH:INSYQ)

CAPS Rating: 2 out of 5

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

61 Outperform
10 Underperform
 

All-Star Players

8 Outperform
3 Underperform
 

Wall Street

0 Outperform
1 Underperform
 

Top NASDAQOTH:INSYQ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

healthcarevalue (83.74)
Submitted November 02, 2016

INSYS Therapeutics, Inc. (INSY). Biotechnology company. Price/earnings last 12 months is 16.9. In 2015 its P/E went as high as 42.0. Return on Invested Capital last 12 months is 21.34. In 2015 it was 27.74. In 2014 it was 30.90. In 2013 it was 96.70.… More

zzlangerhans (99.65)
Submitted June 29, 2015

This is a rising knife stock if ever there was one, so don't expect this to be a real world position any time soon. More than 99% of Insys revenues come from a single drug, Subsys, which is a sublingual spray of the potent opiate fentanyl. If… More

NASDAQOTH:INSYQ VS S&P 500 (SPY)

NASDAQOTH:INSYQ Summary

Fools bullish on NASDAQOTH:INSYQ are also bullish on:

Fools bearish on NASDAQOTH:INSYQ are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INSYQ.

Recs

0
Member Avatar airenInDebt (64.67) Submitted: 9/15/2018 2:16:47 PM : Outperform Start Price: $8.44 NASDAQ OTHER:INSYQ Score: -104.47

The focus on CBD related medicines will eventually propel this stock.

Recs

0
Member Avatar AriGold212855 (64.02) Submitted: 5/12/2017 2:14:54 PM : Underperform Start Price: $11.74 NASDAQ OTHER:INSYQ Score: +128.89

Based on "flopped" earnings and no new products slated till later in the year.

Recs

1
Member Avatar healthcarevalue (83.74) Submitted: 11/2/2016 1:28:26 PM : Outperform Start Price: $11.00 NASDAQ OTHER:INSYQ Score: -146.90

INSYS Therapeutics, Inc. (INSY). Biotechnology company. Price/earnings last 12 months is 16.9. In 2015 its P/E went as high as 42.0. Return on Invested Capital last 12 months is 21.34. In 2015 it was 27.74. In 2014 it was 30.90. In 2013 it was 96.70. Negligible to zero debt/equity ratio shows a very financially healthy company to weather the good times and bad.

Leaderboard

Find the members with the highest scoring picks in INSYQ.

Score Leader

JDusan

JDusan (90.64) Score: +221.14

The Score Leader is the player with the highest score across all their picks in INSYQ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
armycommando 65.60 4/16/2014 Underperform 5Y $18.66 -98.44% +69.22% +167.66 0 Comment
CocaineOrStock 99.23 7/15/2014 Underperform 5Y $12.79 -97.72% +59.04% +156.77 0 Comment
barrywstone 30.87 7/29/2014 Underperform NS $14.63 -98.01% +58.37% +156.38 0 Comment
whatthree16 68.12 12/4/2014 Underperform 5Y $19.07 -98.47% +51.22% +149.70 0 Comment
carmendarez < 20 12/22/2016 Underperform 5Y $9.26 -96.86% +39.12% +135.97 0 Comment
chushogi 68.16 12/13/2016 Underperform 5Y $9.17 -96.83% +38.25% +135.07 0 Comment
AriGold212855 64.02 5/12/2017 Underperform 1Y $11.74 -97.52% +31.37% +128.89 1 Comment
divingfalcon < 20 6/12/2017 Underperform 5Y $11.35 -97.44% +29.09% +126.52 0 Comment
OttoBismarck 99.95 12/18/2018 Underperform 5Y $4.30 -93.23% +23.09% +116.32 0 Comment
airenInDebt 64.67 9/17/2018 Outperform 1Y $8.44 -96.55% +7.92% -104.47 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for INSYQ.